Home/Filings/4/0001104659-15-005435
4//SEC Filing

Dipexium Pharmaceuticals, Inc. 4

Accession 0001104659-15-005435

CIK 0001497504operating

Filed

Jan 28, 7:00 PM ET

Accepted

Jan 29, 5:12 PM ET

Size

5.4 KB

Accession

0001104659-15-005435

Insider Transaction Report

Form 4
Period: 2015-01-05
Shawah Robert G.
Chief Accounting Officer
Transactions
  • Award

    Options

    2015-01-05$11.35/sh+35,000$397,250120.379 total
    Exercise: $11.35Exp: 2025-01-05Common stock, $0.001 par value per share (35,000 underlying)
Footnotes (1)
  • [F1]Options vest as follows: 50% on the date of grant and the remaining 50% vests in equal installments over a 24 month period, subject to accelerated vesting on a change of control.

Documents

1 file

Issuer

Dipexium Pharmaceuticals, Inc.

CIK 0001497504

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001497504

Filing Metadata

Form type
4
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 5:12 PM ET
Size
5.4 KB